tradingkey.logo
tradingkey.logo
Search

Alchemab Therapeutics Signs Landmark $415M Licensing Agreement For ATLX-1282 With Eli Lilly And Company

ReutersMay 6, 2025 11:04 AM
facebooktwitterlinkedin
View all comments0

- Eli Lilly and Co LLY.N:

  • ALCHEMAB THERAPEUTICS SIGNS LANDMARK $415M LICENSING AGREEMENT FOR ATLX-1282 WITH ELI LILLY AND COMPANY

  • ALCHEMAB THERAPEUTICS: AGREEMENT WITH LILLY TO LICENSE ATLX-1282

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI